Cargando…
Topical Administration of Allogeneic Mesenchymal Stromal Cells Seeded in a Collagen Scaffold Augments Wound Healing and Increases Angiogenesis in the Diabetic Rabbit Ulcer
There is a critical clinical need to develop therapies for nonhealing diabetic foot ulcers. Topically applied mesenchymal stromal cells (MSCs) provide a novel treatment to augment diabetic wound healing. A central pathological factor in nonhealing diabetic ulcers is an impaired blood supply. It was...
Autores principales: | O’Loughlin, Aonghus, Kulkarni, Mangesh, Creane, Michael, Vaughan, Erin E., Mooney, Emma, Shaw, Georgina, Murphy, Mary, Dockery, Peter, Pandit, Abhay, O’Brien, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712062/ https://www.ncbi.nlm.nih.gov/pubmed/23423568 http://dx.doi.org/10.2337/db12-1822 |
Ejemplares similares
-
Autologous circulating angiogenic cells treated with osteopontin and delivered via a collagen scaffold enhance wound healing in the alloxan-induced diabetic rabbit ear ulcer model
por: O’Loughlin, Aonghus, et al.
Publicado: (2013) -
Mesenchymal Stem Cell-Based Treatment for Microvascular and Secondary Complications of Diabetes Mellitus
por: Davey, Grace C., et al.
Publicado: (2014) -
Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody
por: Liew, A., et al.
Publicado: (2018) -
Topical interventions for the management of pain in chronic wounds: A protocol for a systematic review
por: Ivory, John D., et al.
Publicado: (2022) -
Effects of thrombin, PAR-1 activating peptide and a PAR-1 antagonist on umbilical artery resistance in vitro
por: O'Loughlin, Aonghus J, et al.
Publicado: (2005)